Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
30.37
-0.70 (-2.25%)
At close: Jan 30, 2026, 4:00 PM EST
30.34
-0.03 (-0.10%)
After-hours: Jan 30, 2026, 4:20 PM EST
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $1.73 billion as of January 30, 2026. Its market cap has increased by 244.76% in one year.
Market Cap
1.73B
Enterprise Value
1.41B
1-Year Change
244.76%
Ranking
Category
Stock Price
$30.37
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $1.73B, an increase of 115.42%. That is a compound annual growth rate of 12.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.73B | -4.41% |
| Dec 31, 2025 | 1.81B | 210.31% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuvation Bio | 1.80B |
| MannKind | 1.77B |
| Syndax Pharmaceuticals | 1.77B |
| Pharvaris | 1.76B |
| Corvus Pharmaceuticals | 1.73B |
| Nurix Therapeutics | 1.70B |
| Zymeworks | 1.69B |
| Upstream Bio | 1.68B |